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Background: Γ-Ionizing radiation (IR) therapy is one of major therapeutic tools in cancer treatment. Nevertheless, γ-IR
therapy failed due to occurrence of metastasis, which constitutes a significant obstacle in cancer treatment. The main aim
of this investigation was to construct animal model which present metastasis during radiotherapy in a mouse system
in vivo and establishes the molecular mechanisms involved.
Materials and methods: The C6L transfectant cell line expressing firefly luciferase (fLuc) was treated with γ-IR, followed
by immunoblotting, zymography and invasion assay in vitro. We additionally employed the C6L transfectant cell line to
construct xenografts in nude mice, which were irradiated with γ-IR. Irradiated xenograft-containing mice were analyzed
via survival curves, measurement of tumor size, and bioluminescence imaging in vivo and ex vivo. Metastatic lesions in
organs of mice were further assessed using RT-PCR, H & E staining and immunohistochemistry.
Results: γ-IR treatment of C6L cells induced epithelial-mesenchymal transition (EMT) and increased cell invasion. In
irradiated xenograft-containing mice, tumor sizes were decreased dramatically and survival rates extended. Almost all
non-irradiated xenograft-containing control mice had died within 4 weeks. However, we also observed luminescence
signals in about 22.5% of γ-IR-treated mice. Intestines or lungs of mice displaying luminescence signals contained several
lesions, which expressed the fLuc gene and presented histological features of cancer tissues as well as expression of EMT
markers.
Conclusions: These findings collectively indicate that occurrences of metastases during γ-IR treatment accompanied
induction of EMT markers, including increased MMP activity. Establishment of a murine metastasis model during γ-IR
treatment should aid in drug development against cancer metastasis and increase our understanding of the mechanisms
underlying the metastatic process.
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Metastasis is one of the distinct characteristics of cancer
and presents a major obstacle to cancer treatment. An
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reproduction in any medium, provided the ormetastasis is thus important to overcome failure of treat-
ment [1]. Induction of metastasis is critically dependent
on the capability of cancer cells to mobilize from the ori-
ginal site. Cancer cells acquiring motility access the vas-
culature of the lymphatic system via invasion, and attach
and proliferate to distant sites with a favorable micro-
environment [1-3]. Metastasis is accomplished when
proliferating cancer cells in secondary sites form another
cell mass that may display different characteristics, in
particular, drug or radioresistance, from the original
cancer, as a consequence of encountering various
microenvironmental and stress factors distinct from
the primary site [4-6]. Therefore, migrating cancer. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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death, and the resistance might depend on activation
of the phosphatidylinositol 3-kinase (PI3Kinase) sig-
naling pathway. Activation of the PI3Kinase pathway
in metastatic cancer cells due to the highly glycolytic
state of the cells [7,8] and aerobic glycolysis could
also induce drug resistance in cancer cells [9,10]. Re-
sistance against anoikis induced upon cell detach-
ment from the extracellular matrix (ECM), might
also be involved in survival of migrating cancer cells
[11,12]. A few reports have suggested that induction
of resistance against anoikis is also derived from ac-
tivation of the PI3Kinase signaling and extracellular
signaling-receptor kinase (ERK) via various proteins
involving TrkB, its ligand brain-derived neurotrophic
factor (BDNF), and hepatocyte growth factor (HGF)
[13,14]. PI3Kinase and ERK may also participate in
cancer cell migration and invasion by activating vari-
ous ECM-degrading enzymes, such as the matrix
metalloproteinase (MMP) family proteins [15-17].
MMP proteins represent one of the major markers
of epithelial-mesenchymal transition (EMT) as well
as metastasis [18]. Recent studies have shown that EMT is
a fundamental cellular mechanism, promoting cell migra-
tion and loss of cell polarity during organ formation and
differentiation. Development of gastrulation, neural systems
and various internal organs, such as pancreas and liver, are
required from induction of EMT [19,20]. In cancer, EMT
plays various roles in the maintenance of cancer stemness
and induction of metastasis, and is inducible by different
growth factors, hormones, and intracellular molecules. Sev-
eral regulators, such as Snail, Twist1 and SIP1, have been
shown to mediate EMT and metastasis under signaling of
hypoxia/HIF-1, Wnt, Notch, and TGF-β. Environmental
factors, including nicotine, ultraviolet light (UV) and γ-IR,
also promote EMT [20-22]. Induction of EMT appears to
be related to resistance against chemotherapy reagents,
such as tamoxifen and gemcitabine, as well as radiotherapy
[23-25]. Furthermore, EMT stimulates acquisition of elon-
gated cancer cell survival during movement from the pri-
mary cancer to distal metastasis site [26].
Around 50% of all solid cancer patients receive radiation
therapy, one of the major current treatment methods. How-
ever, recent reports have demonstrated that γ-IR induces an
increase in invasiveness of several cancer cell types, includ-
ing glioma, hepatocellular carcinoma, and lung cancer cells
[22,27,28]. This increase in invasiveness is accomplished via
enhanced activity and expression of MMP family proteins
promoted by various intracellular pro-survival signaling
pathways, such as NF-κB and PI3-kinase/AKT. These pro-
teins are known cell survival factors that endow resistance
against various stress conditions [29-32].
In the present study, we attempted to establish whether
γ-IR-induced invasion and metastasis are stimulated inour in vitro C6L cell line and in vivo systems, and further
identify the associated changes in signal pathways or mice
physiology. We constructed an animal model system with
a view to clarifying the intracellular molecular events
underlying the promotion of metastasis after γ-IR treat-
ment for primary cancer and developing effective anti-
metastatic reagents. Our results demonstrate that γ-IR
treatment of cancer cell lines and mice xenografts triggers
invasion and metastasis. In particular, γ-IR-treated cancer
cells or mouse xenografts and metastatic lesions in mice
bearing γ-IR-treated xenografts also display typical EMT
marker expression patterns, such as increased vimentin or
MMP-2 expression, decreased E-cadherin, and enhanced
activity of MMP-2. Our results collectively suggest that γ-
IR-induced invasion or metastasis results from induction
of EMT, and inhibition of EMT may thus be a means to
enhance the effectiveness of radiation therapy.
Materials and methods
Cell culture and irradiation of γ-IR
Rat glioma cell C6 cells were obtained from American
Type Culture Collection (Rockville, MD), and grown in
DMEM (Invitrogen, Grand Island, NY) supplemented
with 10% fetal bovine serum (Invitrogen) in a humidified
5% CO2 incubator at 37°C. We employed C6 to con-
struct C6L transfectant cells containing the firefly luci-
ferase (fLuc) gene in lentiviral vectors and selected with
blastidin treatment (5 mg/mL). Irradiation with various
doses of γ-IR was performed with a γ-IR irradiator using
137Cs as a source of γ-rays (Atomic Energy of Canada,
Ltd., Mississauga, ON).
PCR analysis
Total RNA was isolated from metastatic lesions, and
used as a template to produce cDNA using SuperScript
III First-Strand Synthesis for RT-PCR (Invitrogen, CA).
Synthesized cDNA was amplified using Taq DNA poly-
merase (iNtRON, Seoul) with the following primers for
fLuc: forward, 5’- CGC CTT GAT TGA CAA GGA
TGG, and reverse, 5’- GGC CTT TAT GAG GAT CTC
TCT. The forward primer used for glyceraldehyde-3-
phosphate dehydrogenase (GADPH) was 5’- GGT GAA
GGT CGG TGT GAA CG and the reverse primer was
5’- CTC GCT CCT GGA AGA TGG TG.
Invasion analysis
C6L cells were seeded in a 35 mm cell culture dish and
irradiated with 1, 3, 5, or 7 Gy of γ-IR. Transwell sys-
tems containing a 0.8 μm pore (Corning, NY) were
coated with Matrigel (1 mg/mL, Invitrogen), and pre-
irradiated cells (2 × 104) were washed with serum-free
media twice after 18 h of irradiation. Cells were added
to the upper chamber and serum-free medium contain-
ing 0.1% BSA added to the lower chamber of each
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Cell staining was performed with deep quick solution
(Merck, Whitehouse Station, NJ), according to the man-
ufacturer’s protocol. Photographs of microscopic images
of stained cells were taken under a microscope and
counted, and then statistical analyses were performed.
Immunoblot analysis
C6L cells were seeded in a 60 mm cell culture dish and
irradiated with 3 Gy of γ-IR. Irradiated cells were trypsi-
nized and washed with 1× ice-cold PBS. RIPA buffer
[50 mmol/L Tris, pH.8.0, 150 mmol/L NaCl, 1% NP-40,
0.5% deoxycholic acid, and 0.1% sodium dodecyl sulfate
(SDS)] containing protease and phosphatase inhibitor
cocktail (Sigma) was used to dissolve harvested cell pellets
for acquiring whole-cell protein lysates. Cell lysates were
separated by 12% SDS-polyacrylamide gel electrophoresis
(PAGE) and transferred to nitrocellulose membranes
(Invitrogen Co., Carlsbad, CA). Protein-transferred mem-
branes were incubated with primary antibodies against E-
cadherin, MMP-2 (Santa Cruz Biotechnology, Santa Cruz,
CA) or Vimentin (Dako, Glostrup, Denmark). Primary
antibody-attached membranes were washed with PBS-
Tween 20 (PBS-T) and incubated with the appropriate
secondary antibody. A chemiluminescence kit (Thermo
scientific, Rockford, IL) was used to detect target proteins
on the nitrocellulose membrane.
Gelatin zymography
C6L cells were irradiated with 3 Gy, and the media of
irradiated cells replaced with serum-free medium. Cells
were incubated for 24 h in serum-free medium under a
humidified atmosphere with 5% CO2 at 37°C, collected
and loaded on to a 0.1% gelatin SDS-PAGE gel (10%).
After separation of proteins, gel renaturation was per-
formed with 2.5% Triton X-100 buffer for 1 h, and the
gelatin gel incubated with developing solution (50 mM
Tris pH 7.5, 20 mM NaCl, 10 mM CaCl2, 1 μM ZnCl2,
0.1% NaN3) for 24 h at 37°C, followed by staining with
5% Coomassie Brilliant Blue (Sigma, St. Louis, MO).
Propidium iodide (PI) uptake analysis
A PI uptake analysis was performed, as described in our
previous report [33], to detect γ-IR-induced cell death
on C6L cells. C6L cell samples were prepared as for the
invasion analysis; C6L cells were seeded in a 35-mm cell
culture dish and cultured overnight. The seeded cells
were irradiated with 1, 3, 5, 7 Gy of γ-IR, and then incu-
bated for an additional 18 hours. The cells were har-
vested and stained with PI solution (5 mg/mL, Sigma, St.
Louis, MO, USA), and then analyzed with a BD FACS-
Calibur flow cytometer (BD Biosciences, San Jose, CA,
USA).Formation of Xenografts and Irradiation with γ-ionizing
radiation
C6L cells (5 × 105) were injected s.c. into the right hind legs
of 6 week-old BALB/cAnNCrj-nu/nu mice (Charles River
Japan, Inc., Tokyo) to construct xenografts, as described in
a previous report by Park et al. [34]. Xenografts reaching
more than 100 mm3 were treated with γ-IR at 10 Gy per
day for 5 days, but not the mock control group. Mice were
anesthetized i.p. with Zoletil 50™ (VIRBAC Laboratories,
Carros) and fixed on an acryl plate. Xenografts were locally
irradiated with a 60Co γ-IR source (Theratrom 780; AECL,
Ltd., Mississauga, ON), while other body parts were pro-
tected with lead blocks. Tumor sizes and survival curves of
the control or radiation-treated groups were assessed for
62 days. Tumor sizes were established with a caliper rule
(Mitutoyo Co. Japan), and the volume of each xenograft
calculated as follows: [(short axis2 × long axis)/2].
Bioluminescence imaging acquisition
Bioluminescence imaging was performed with a CCD cam-
era mounted in a light-tight specimen chamber (IVIS200,
Xenogen, CA). For in vivo imaging, mice were administered
100 μL of 2.5 mg/100 μL D-luciferin potassium salt i.p. and
anesthetized with 2% isoflurane. Imaging and quantification
of signals were controlled with the acquisition and analysis
software Living Image V. 2.50 (Xenogen), as described pre-
viously by Jang et al. [35].
Histological analysis and Immunohistochemistry
To perform histological analysis, metastatic lesions were
fixed with formaldehyde and embedded in a paraffin
block. Sliced tissues were stained Hematoxylin & Eosin
solution, and histological analysis performed under a
microscope. Immunohistochemistry for the detection of
EMT markers in lesions was also performed with the
CAP-PLUS™ Broad Spectrum kit (Zymed Laboratories
Inc. South San Francisco, CA), as described in the man-
ufacturer's protocol. Tissue sections of the lesions were
deparaffinized with xylene, rehydrated, and incubated in
citric acid buffer (0.01 M, pH 6.0) for 20 min at 100°C.
Incubated sections were cooled slowly at room
temperature for 20 min, and endogenous peroxidase
activity blocked by treatment with H2O2 for 15 min.
Sections were incubated with primary antibodies (anti-
Vimentin and anti-E-cadherin) overnight at 4°C and
washed with 0.05% Tween 20-containing PBS buffer
three times. Secondary antibody, streptavidin, and DAB
were sequentially added to the sections for visualization
of vimentin and E-cadherin, followed by treatment with
autohematoxylin for counterstaining of nuclei.
Statistical analysis
All experiments were repeated at least three times, but
Figures 1B and 1E were performed at duplicate. Data
Figure 1 Γ-IR promotes invasion of C6L cells through induction of EMT. (A) C6L, stably transfected cells containing the firefly luciferase gene,
was constructed from Rat glioma C6 cells. (B) C6L transfectants were seeded and treated with 1, 3, 5, or 7 Gy of γ-IR, and the invasion assay
performed as described in Materials and methods. C6L/no IR represents untreated mock control and C6L/1, 3, 5, or 7 Gy the γ-IR-treated groups.
The p values of the C6L/no IR and C6L/3 Gy groups were determined with the t-test. **: p< 0.01 (p value = 0.001). (C) Propidium iodide (PI)
uptake analysis. C6L/no IR represents the γ-IR-untreated mock control, and C6L/1, 3, 5, or 7 Gy represents the γ-IR-treated groups. (D) C6L
transfectants were treated with 3 Gy of γ-IR, and immunoblot and gelatin zymography analyses performed. No γ-IR represents untreated mock
control and 3 Gy signifies the γ-IR–treated groups. (E) Treatment of xenografts with γ-IR also induced EMT, which was detected with IHC (200×).
No γ-IR indicates γ-IR-untreated mock control and 10 Gy is the γ-IR-treated group. Γ-IR treatment (10 Gy) was performed as described in
Figure 2A, and the tissues collected on day 35 after injection of C6L.
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INC. CA), and differences between the experimental
groups determined using a t-test and one way-ANOVA.
Error bars indicate standard deviations (SD), and p-values
were calculated.
Results
Γ-IR promotes invasiveness via induction of EMT in vitro
and in vivo
In this study, we investigated the possibility that γ-IR
promotes metastasis in an in vivo murine model system.
We constructed a firefly luciferase (fLuc)-expressing
C6L transfectant cell line derived from the rat glioma
cell line, C6. Construction of the C6L cell line was con-
firmed with PCR analysis using firefly luciferase primer
and GAPDH (Figure 1A). We observed expression of ex-
ogenous fLuc gene in the C6L cell line, but no detectable
fLuc gene in C6 cells. This result implies that expression
of fLuc is a prominent selective marker in the mouse
system in vivo in addition to bioluminescent assay
in vitro. Enhanced invasion of C6L cells following γ-IR
treatment was detected in a dose-dependent manner
based on quantitative analysis using matrigel-coated
transwells (Figure 1B). Treatment with 3 Gy of γ-IR
induced the maximum increase in C6L cell invasion by
more than two-fold. But treatments of γ-IR in a dose-
dependent manner did not affect C6L cell survival
(Figure 1C). To further elucidate the intracellular signal-
ing machinery underlying the γ-IR-induced increase in
the invasive ability of C6L, we performed immunoblot
analysis with the EMT markers, E-cadherin, vimentin,
and MMP-2 (Figure 1C upper panel). We detected
decreased E-cadherin expression and increased vimen-
tin/MMP-2 expression, concurrent with the typical in-
duction patterns of EMT markers. Increased MMP-2
activity was also observed with the gelatin zymography
assay (Figure 1C, lower panel). In another preliminary
experiment, we treated xenografts with 10 Gy of γ-IR,
and isolated the tissue for IHC analyses with EMT mar-
kers (Figure 1D). IHC analysis with anti-E-cadherin or
anti-vimentin antibodies revealed a decrease in E-
cadherin and increase in vimentin expression, respect-
ively. Based on these findings, we propose that induction
of EMT might be the underlying cause of γ-IR-induced
metastasis.
Γ-IR caused regression of tumors and prolonged survival
but did not block death of the in vivo model perfectly
To further establish whether γ-IR induces metastasis of
cancer in vivo, we constructed xenografts with 5 × 105
C6L cells irradiated with γ-IR, as described in Materials
and methods. The experimental schedule in which bio-
luminescence images were detected every 7 days from
day 35 is presented in Figure 2A. Preliminary studies onxenograft size and survival in mice subjected to γ-IR
treatment were performed (Figures 1A and 2B). We cal-
culated the time-periods needed for xenograft sizes of
each group to reach 2500 mm3 (Figure 2B). Notably, the
control group reached this size in 4 days and the γ-IR
treatment group in 45.7 days, revealing a 41.3-day
growth delay in terms of xenograft size (Figure 2B).
With regard to survival rates, 50% of γ-IR-treated mice
survived until day 61, while control mice did not survive
for more than 44 days (Figure 2C). Our results indicate
that a total of 50 Gy of γ-IR effectively reduces xenograft
size and extends survival in mice, but does not eliminate
the tumor completely. Failure of complete tumor eradi-
cation by γ-IR suggests the possibility of tumor recur-
rence. As shown in Figures 2B and 2C, rapid tumor
growth and death of mice in the γ-IR treatment group
were detected from day 40. Death of mice displaying
smaller tumor sizes in the γ-IR treatment group, com-
pared to those in the control group indicates the occur-
rence of metastasis at a secondary site.
Metastases following γ-IR treatment were detected in the
murine in vivo model
Metastasis from the primary site to internal organs fol-
lowing γ-IR treatment was detected with biolumines-
cence imaging in vivo and ex vivo using fLuc activity of
C6L cells in xenografts. We constructed xenografts of 40
mice in total and treated them with γ-IR, as shown in
Figure 2A. Bioluminescence images were detected, as
described in Materials and methods. Bioluminescence
signals in the body trunks of mice, except the xenograft
sites, were observed in 9 (22.5%) among the 40 mice.
Specifically, 5 mice displaying bioluminescence pre-
sented signals in the chest region and 4 in the abdomen
region (Figures 3A and 3B). To ascertain the occurrence
of metastasis and the exact site, mice were sacrificed,
and bioluminescence imaging (ex vivo bioluminescence
image) was performed again with the abdomen open to
obtain the precise location of tumor growth in organs
including brains. Ex vivo bioluminescence images were
detected in 3 among 5 mice displaying signals in the
chest region (Figure 3A). Lung metastases were observed
in ex vivo bioluminescence images, but brain metastases
were not. Relationship analysis of fLuc activity with
tumor volume in vivo indicated a time-dependent in-
crease in signal intensity (Figures 3C and 3D).
Metastases in the animal model may be accompanied by
EMT induction
Although ex vivo bioluminescence image analysis failed
to completely reveal bioluminescence signals in mice
subjected to whole autopsy, several lesions estimated as
neoplasms in the lung and intestine were observed with
visual assessment (Figure 4A). Lesions were further
Figure 2 Treatment with γ-IR affects tumor size and percentage survival in mice. (A) Radiation treatment schedule (scheme, upper part)
and occurrence of metastasis detected with bioluminescence imaging (box, lower part). (B) Detection of tumor sizes. Radiation (black square)
indicates the γ-IR-treated group (n= 5) and control (white square) signifies the control group (n= 4). Tumor sizes of mice were detected as long
and short axis lengths, and calculated as follows: (short axis length2 × long axis length)/2. The p values between γ-IR-treated and control groups
were calculated with the t-test. *: p< 0.01 (p value = 0.0014). (C) Survival rates of mice. Survival rate was calculated as a percentage of each group.
The p values between γ-IR-treated and control groups were obtained with the t-test. *: p< 0.01 (p value = 0.0063).
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(Figure 4B) and histological experiments (Figure 4C). As
shown in Figure 4B, each lesion expressed the fLuc gene,
indicative of its origin from C6L xenografts as a primary
cancer. H & E staining in histological analysis revealed
the formation of solid tumors in normal lung and intes-
tine tissues (Figure 4C). These results suggest that γ-IR
promotes metastasis in vivo as well as in vitro, and in-
duction of cancer spread by irradiation is accomplished
randomly. To identify changes in intracellular signaling
or physiological phenomena occurring in γ-IR-induced
metastasis, we assessed the expression of ECM markers
in histological tissue samples (Figure 4D). IHC analysis
with E-cadherin or vimentin disclosed different expres-
sion patterns in cancer and normal sites. Specifically, E-
cadherin was expressed at the normal site in each tissue
(lung and intestine), while vimentin was expressed at the
cancer site in each tissue, especially in the intestine,
where expression was detected in the lesion center.Discussion
Although γ-IR is one of most useful known tools for
cancer treatment to date, many investigators have
reported metastasis from primary cancer following ir-
radiation. As reported previously in a review by C.F. von
Essen [36], various researchers have described two dis-
tinct cases of metastasis induced by γ-IR, whereby (1)
increased metastasis is triggered following local irradi-
ation against primary cancer, and (2) localization of me-
tastases is increased in γ-IR-pretreated normal tissues.
In the current study, we have demonstrated that γ-IR
treatment of primary cancer xenografts of the C6L cell
line induces distant metastasis in vivo and enhances the
invasiveness of C6L in vitro via induction of EMT. We
generated a C6L cell line expressing fLuc from parental
C6 and further examined whether local γ-IR treatment
of xenografts constructed from our cell line promotes
distant metastasis. In our previous report [35], we used
C6 cells to construct C6TL cells containing the herpes
Figure 3 Detection of metastasis of γ-IR-treated mice using bioluminescence imaging. Xenograft formation and γ-IR treatment were
performed as described in Materials and methods. Images were detected over a week between weeks 3 and 9 of radiation treatment.
Bioluminescence imaging of metastasis was performed after mice were anesthetized with isoflurane in a live state. (A) Bioluminescence images of
metastasis in the lungs. The upper Figure represents the schedule of bioluminescence imaging and lower box indicates the number of
metastases and total mice. Bioluminescence images of metastasis in the lung. The horizontal number indicates the week and the vertical number
represents each mouse. Ex vivo images including brains were also detected in the last week (mouse numbers 1, 2, and 4). (B) Bioluminescence
images of metastasis in the intestine. The horizontal number indicates the week and the vertical number represents each mouse. (C and D)
Relationship analysis of fLuc activity and tumor volume of mice (numbers 1 and 5) in the lung metastasis group.
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firefly luciferase (fLuc) genes for gene therapy against
glioma and found that the genetically modified C6 cell
line is a very effective monitoring system for Biolumines-
cence imaging or microPET due to their high fLuc activ-
ity and iodine-125 iodovinyldeoxyuridine uptake. We
used nude mice, because the entire body of hairless nudemice provided a chance to observe the Bioluminescence
signal more efficiently in the body trunk. C6L was ini-
tially generated from the C6 rat glioma cell line derived
from C6 glioblastoma tumors in Sprague–Dawley and
Wistar rats, which display significant invasion and a dif-
fuse infiltrating border in which each C6 cell moves to
normal brain tissue beside the tumor area [37]. Thus, C6
Figure 4 Histological or genetic analysis of metastatic lesions. (A) Mice displaying bioluminescence signals upon imaging were scarified and
dissected. Lesions in the lung and intestine were observed (black arrows and circles). (B) The fLuc gene in lesions was detected with PCR. (C)
Histological analysis revealed that each lesion displays characteristics typical of cancer tissue (200×). (D) IHC analysis. E-cadherin was expressed in
normal tissue, while vimentin was expressed in cancer tissue (N: normal tissue, C: cancer tissue) [200× except to vimentin staining of intestine
(100×)]. (E) Scheme of γ-IR – induced metastasis.
Park et al. Radiation Oncology 2012, 7:153 Page 8 of 11
http://www.ro-journal.com/content/7/1/153could be useful to investigate invasion of glioma as a
glioblastoma model system. Park et al. [28] demon-
strated that γ-IR treatment increases invasion through
activity or expression of MMP-2 via activation of Src/
epidermal growth factor receptor-mediated p38/Akt and
PI3-Kinase/Akt signaling in various non-functional
PTEN-bearing glioma cells, including C6. We addition-
ally showed that irradiation of the C6L cell line via in-
duction of EMT (Figure 1C). Our results are consistent
with previous reports showing that γ-IR-treated non-
small cell lung cancer (NSCLC) cell lines display
increased invasion via EMT induction, characterized by
activation of MMP protein [22,38]. Moreover, we
demonstrated previously that γ-IR promotes the level of
Bcl-xL, a pro-survival protein, in a manner dependent
on signal transducer and activator of transcription 3
(STAT3) phosphorylation [22]. Treatment with γ-IR also
enhanced invasion of hepatocellular carcinoma cell
(HCC) cell lines via the PI3-Kinase/Akt/NF-κB/MMP-9
pathway [27].
Next, we performed experiments to establish whether
the increased invasiveness of C6L by γ-IR promotes me-
tastasis in vivo. The schedule for γ-IR treatment of xeno-
grafts was followed as described by Camphausen et al.
[39], who used Lewis lung carcinoma (LLC-LM) cells toconfirm that γ-IR promotes metastasis in an animal
model and suggested that increased levels of MMP-2
may be related to enhancement of metastases. Survival
and tumor sizes in mice showed that local γ-IR treat-
ment decreases tumor size and elongates survival of
mice but do not block metastasis completely. C.F. von
Essen also suggested three possible mechanisms under-
lying the promotion of metastases by local irradiation,
specifically, (1) direct alterations in γ-IR-treated cancer
cells (2) promotion of entry of cancer cells into the cir-
culation, and (3) extension of time needed for entry of
cancer cells into the circulation. Data from the present
study indicate that γ-IR treatment can elongate survival
times in mice, leading to entry of cancer cells into the
circulation. Thus, the third hypothesis of C.F. von Essen
is consistent with our results. We need to test the other
hypotheses in future studies to clarify the molecular
mechanism underlying γ-IR-induced metastasis.
To detect the occurrence of metastasis in internal
organs of the in vivo murine system, we used the bio-
luminescence imaging system containing charged
coupled device (CDD) detectors. As this system provides
noninvasive in vivo optical images, we traced the occur-
rence of metastasis during several weeks. Molecular im-
aging techniques are based on nuclear medicine that is
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injection of radiolabeled tracers [40]. As recent develop-
ment of bioluminescence imaging systems results from
advances in molecular biology and biochemistry, the
technique consists of optical imaging systems with fluor-
escence imaging whereby molecular probes are required
to detect specific signals in living subjects. Various bio-
compatible molecular probes, including chemicals and
reporter genes, have been used for optical imaging. In
particular, several intracellular reporter genes have
been developed and applied, including GFP, thymidine
kinase, cytosine deaminase, tyrosinase, and luciferase
[41]. Luciferases constitute a family of enzymes origin-
ating from diverse fireflies or beetles that emit their
own specific wavelength of light using specific sub-
strates and biochemical pathways [42]. As shown in
Figures 3A and 3B, we detected bioluminescence signals
in the chest or abdomen of living mice, which were
regarded as metastatic lesions. Some mice showed
increased bioluminescence signals in a time-dependent
manner in a relationship analysis of fLuc activity. Ex
vivo image detection of bioluminescence signals at the
final step was also performed to confirm the signals in
body trunks of mice. Our results provide evidence that
optical bioluminescence signal detection is a useful
non-invasive diagnostic tool for metastasis.
We observed several metastatic lesions in the lung or
intestine after autopsy. Interestingly, metastatic lesions
were not detected in several internal organs simultan-
eously in each mouse, but the possibility that undetected
metastatic lesions in other visceral organs were discov-
ered remained, because we did not perform a complete
dissection of the entire mouse. Metastatic lesions of the
lung were identified with hardened tissues, and those of
the intestine formed white, small-sized cysts. RT-PCR
results obtained using RNA from metastatic lesion tis-
sues indicated that these lesions contain the fLuc gene
and therefore originate from C6L cells in the primary
cancer located a distance away. Histological analysis with
H & E staining revealed that the metastatic lesions are
typical cancerous lesions with poorly differentiated
morphology, compared with those of healthy lung and
intestine tissue. IHC examination with anti-E-cadherin
and anti-vimentin antibodies further showed that cancer
sites in metastatic lesions contain low E-cadherin/high
vimentin levels, while conversely, normal tissue sites
present with high E-cadherin/low vimentin expression
levels. These results were inconsistent with the typical
EMT theory hypothesizing that increases in cancer cell
migration/invasion via induction of EMT promote can-
cer cell movement to a new site for metastasis formation
and that mesenchymal-to-epithelial transition (MET) is
required for settlement of cancer cells [19,43]. However,
several clinical reports indicate that loss of E-cadherin ingastric/colorectal cancer and increased vimentin expres-
sion in NSCLC/gastric cancer are markers for cancer
progression, metastasis and poorer prognosis [44-47].
Therefore, we could postulate that MET might be a
transient event that is induced to promote formation of
the metastasis site, followed by progression of metastatic
lesions.
However, there are other possibilities that EMT might
not be the main or only cause of radiation-induced metas-
tasis in our system, because Tarin et al. reported no con-
firmative evidence that EMT can be induced in vivo [48].
Instead, fused hybrids of macrophages and non-metastatic
cancer stem cells can metastasize in vivo [49-51]. More-
over, Mor-Vaknin et al. reported that activated macro-
phages induce secretion of vimentin and up-regulate
MMP proteins [52]. Because radiation might be a cause of
macrophage-cancer cell fusion [53,54], fusion hybrids of
macrophages and cancer cells in our system might be dis-
covered. According to Kliopp et al. irradiated tumors re-
cruit circulating mesenchymal stem cells into their
microenvironment by increasing expression of several
cytokines that might activate macrophages [55]. These
previous reports suggest that further studies on the rela-
tionship between the immune system and radiation-
related metastasis are needed to validate our animal
model. EMT expression markers at distal metastatic
lesions are also required to investigate the relationship
with the immune system.
Together, our results suggest that radiotherapy alone
could promote metastasis as an undesired effect and γ-
IR-induced metastasis in vivo is evoked via the EMT
pathway. Data obtained with our in vivo animal model
may be employed for the development of drugs blocking
radiation-induced metastasis. In previous reports, ad-
ministration of recombinant angiostatin after cancer cell
injection in vivo blocked the formation of metastases by
γ-IR [39], and neutralization of TGF-β with its specific
antibody inhibited γ-IR-induced metastasis [56]. Al-
though molecular targets for blockage of γ-IR-induced
metastases in our system are yet to be identified, the
EMT pathway may be a significant candidate for drug
development. In fact, upstream molecules of the EMT
pathway, including TGF-β receptor, integrin, Wnt, or
Notch signaling, represent targets for anti-cancer drug
development [20,57]. Development of novel drugs to
block γ-IR-induced metastasis may maximize the benefi-
cial effects of radiotherapy and improve treatment
outcomes.
Conclusion
This study is focused on the construction of an animal
model for the development of inhibitor to block the
metastatic process which occurs during radiotherapy.
Γ-IR treatment did not block the occurrence of
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http://www.ro-journal.com/content/7/1/153metastases in mice containing xenografts of C6L cells.
Induction of EMT markers was detected in γ-IR – trea-
ted cells, xenografts, and metastatic lesions in mice.
Therefore, our results also suggested EMT might be one
of the major therapeutic targets to block metastasis
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